Most sold biotechnology stocks in Q1 2018
See which Biotechnology stocks institutional investors trimmed or exited the most in Q1 2018, measured as net reductions in reported share positions from Q4 2017 into Q1 2018. These rankings aggregate SEC 13F filings from all institutional investors in our database.
No data available.
No chart data.
Frequently asked questions about Most sold biotechnology stocks in Q1 2018
What are the most sold Biotechnology stocks in Q1 2018?
The most sold biotechnology stocks in Q1 2018 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2017, based on SEC 13F filings.
Which biotechnology stocks did institutional investors trimmed or exited the most in Q1 2018?
The table above ranks tickers by net change in reported shares; when data is available, the largest decreases appear at the top.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.